Skip to main content

View full-text article in PMC

. 2016 Aug 20;7(38):61789–61805. doi: 10.18632/oncotarget.11442

Table 6. PCR Primers.

Identifier	Experiment	Sequence^a
CK2α-LCK-FOR-Gen1-H2	RNAi-CK2 response	TCATGAGCACAGAAAGCTACGAcTAATC^b
CK2α-LCK-REV-Gen1	RNAi-CK2 response	ATACAACCCAAACTCCACATATCC
CK2α-LCK-Internal	RNAi-CK2 response	TGTCCGAGTTGCTTCCCGATACTT^c
CK2αp′-LCK-FOR-Gen1-H2	RNAi-CK2 response	GGAGTTTGGGCTGTATGTTAGCaAGCAC^b
CK2αp′-LCK-REV-Gen1	RNAi-CK2 response	GTACCCAGAACCTTGGCAATG
CK2αp′-LCK-Internal	RNAi-CK2 response	TGGACAGGACAACTATGACCAGCT^c
LCK-fw	Bioavailability	CGAGATACAACCCAAACTCCA
U6-fw	Bioavailability	CTCGCTTCGGCAGCACA
miRNA-rev	Bioavailability	GCAGGGTCCGAGGTATTC
SLPoly(A)	Bioavailability	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGG ATACGACAAAAAAAAAAAAAAAAAAVN^d
SLPoly(A)-LCK	Bioavailability	GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGA TACGACAAAAAAAAAAAAAAAAAAATGT

^a

Upper case letters = DNA; lower case letters = RNA.

^b

3′ C3 spacer.

^c

Internal reporter = FAM; Quenchers = Internal ZEN & 3′ Iowa Black FQ.

^d

V = A, C or G; N = A, C, G or T.